CoChat

Transcription factor NRF2 as a promising therapeutic target for Alzheimer’s disease

Qu, Zhuo, Sun, Jiachen, Zhang, Wannian, Yu, Jianqiang, Zhuang, Chunlin · 2020 · Free Radical Biology and Medicine
Cited by 137

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Abstract

Oxidative stress is considered as one of the pathogenesis of Alzheimer's disease (AD) and plays an important role in the occurrence and development of AD. Nuclear factor erythroid 2 related factor 2 (NRF2) is a key regulatory of oxidative stress defence. There is growing evidence indicating the relationship between NRF2 and AD. NRF2 activation mitigates multiple pathogenic processes involved in AD by upregulating antioxidative defense, inhibiting neuroinflammation, improving mitochondrial function, maintaining proteostasis, and inhibiting ferroptosis. In addition, several NRF2 activators are currently being evaluated as AD therapeutic agents in clinical trials. Thus, targeting NRF2 has been the focus of a new strategy for prevention and treatment of AD. In this review, the role of NRF2 in AD and the NRF2 activators advanced into clinical and preclinical studies will be summarzied.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.freeradbiomed.2020.06.028

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 137

Metadata

Authors
Qu, Z., Sun, J., Zhang, W., Yu, J., & Zhuang, C.
Venue
Free Radical Biology and Medicine
Publisher
Elsevier BV
Published
2020-11
Volume
159
Pages
87-102
ISSN
0891-5849 (ISSN-L)
OpenAlex
W3045540118
Cited by
137
References
58
FWCI
4.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transcription factor NRF2 as a promising therapeutic target for Alzheimer’s disease. https://app.cochat.ai/papers/10.1016/j.freeradbiomed.2020.06.028
The paper
Qu, Z., Sun, J., Zhang, W., Yu, J., & Zhuang, C. (2020). Transcription factor NRF2 as a promising therapeutic target for Alzheimer’s disease. Free Radical Biology and Medicine. https://doi.org/10.1016/j.freeradbiomed.2020.06.028

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.